Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Johnson and Johnson
Dow
McKinsey
Moodys

Last Updated: September 26, 2022

Details for New Drug Application (NDA): 206621


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 206621 describes DIHYDROERGOTAMINE MESYLATE, which is a drug marketed by Hikma, Hikma Pharms, Padagis Us, Provepharm Sas, Sagent Pharms Inc, Amneal, Cipla, and Custopharm Inc, and is included in eight NDAs. It is available from eight suppliers. Additional details are available on the DIHYDROERGOTAMINE MESYLATE profile page.

The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 206621
Tradename:DIHYDROERGOTAMINE MESYLATE
Applicant:Hikma Pharms
Ingredient:dihydroergotamine mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 206621
Medical Subject Heading (MeSH) Categories for 206621
Suppliers and Packaging for NDA: 206621
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 206621 ANDA Hikma Pharmaceuticals USA Inc. 0143-9273 0143-9273-10 10 AMPULE in 1 CARTON (0143-9273-10) > 1 mL in 1 AMPULE (0143-9273-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Sep 15, 2017TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Colorcon
McKesson
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.